Le marché des contrôles de qualité moléculaires devrait atteindre 372,64 millions de dollars US en 2028 contre 184,62 millions de dollars US en 2021 ; on estime qu'il croîtra à un TCAC de 10,6 % au cours de la période 2021-2028.
Les contrôles de qualité moléculaire aident à surveiller les performances des procédures de test. Ces tests sont utiles pour obtenir des informations de diagnostic critiques et précises. Ces contrôles sont également utilisés pour déterminer les maladies transmissibles et génétiques. De plus, les contrôles de qualité moléculaire aident également à surveiller les performances des protocoles de test d'acide nucléique pour les infections nosocomiales, les tests de charge virale et les infections sexuellement transmissibles. La croissance du marché des contrôles de qualité moléculaire est attribuée à des facteurs tels que l'augmentation des fonds pour la génomique, la baisse du coût des procédures de séquençage et la prévalence croissante des maladies génétiques qui alimentent la croissance du marché. Cependant, la pénurie de professionnels qualifiés entrave la croissance du marché.
Régions lucratives pour le marché des contrôles de qualité moléculaires
Aperçu du marché
Augmentation de la prévalence des maladies génétiques
Les contrôles de qualité moléculaires sont utilisés pour détecter les maladies génétiques car ils facilitent l'interprétation des résultats. Le syndrome de Down est une maladie génétique due à une division cellulaire anormale, qui entraîne une copie supplémentaire complète ou partielle du chromosome 21. Selon les Centers for Disease Control and Prevention (CDC) des États-Unis, chaque année, environ 6 000 nouveau-nés aux États-Unis souffrent du syndrome de Down. En conséquence, le dépistage prénatal du syndrome de Down est en augmentation dans le pays.
La plupart des cas héréditaires de cancer du sein sont associés à des mutations de deux gènes : BRCA1 (gène 1 du cancer du sein) et BRCA2 (gène 2 du cancer du sein). Selon l'American Cancer Society, environ 5 à 10 % des cas de cancer du sein sont héréditaires, à la suite de gènes mutés transmis des parents aux enfants. La sensibilisation croissante au cancer du sein augmente l'adoption des tests génétiques pour le cancer du sein héréditaire.
De plus, selon le CDC, la drépanocytose (SCD) est une maladie génétique du sang courante aux États-Unis qui touche environ 70 000 à 100 000 Américains. De plus, selon l'OMS, 5% de la population mondiale est porteuse des gènes des troubles de l'hémoglobine, tels que la drépanocytose et la thalassémie. Ainsi, la prévalence croissante de ces maladies génétiques propulse la demande de contrôles de qualité moléculaires.
Perspectives basées sur les produits
Basé sur le produit, le marché des contrôles de qualité moléculaires est segmenté en contrôles indépendants et contrôles spécifiques à l'instrument. Le segment des contrôles indépendants détenait une plus grande part du marché en 2020, alors qu'il devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.
Marché des contrôles de qualité moléculaires, par produit - 2020 et 2028
Insights basés sur le type d'analyte
Sur la base du type d'analyte, le marché des contrôles de qualité moléculaires est segmenté en contrôles à analyte unique et contrôles à analyte multiple. Le segment des contrôles à analyte unique détenait une plus grande part du marché en 2021, tandis que le segment de contrôle multi-analyte devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.
Insights basés sur les applications
Sur la base des applications, le marché du contrôle qualité moléculaire est segmenté en maladies infectieuses, oncologie, tests génétiques et autres applications. Le segment des maladies infectieuses détenait la plus grande part du marché en 2021, tandis que le segment de l'oncologie devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.
Insights basés sur les canaux de distribution
< p> Basé sur l'utilisateur final, le marché du contrôle de la qualité moléculaire est segmenté en laboratoires cliniques, hôpitaux, fabricants de DIV et organismes de recherche sous contrat, instituts universitaires et de recherche et autres utilisateurs finaux. Le segment des laboratoires cliniques détenait la plus grande part du marché en 2021 et on estime qu'il enregistrera le TCAC le plus élevé du marché au cours de la période de prévision.
Perspectives stratégiques
Les lancements et les approbations de produits sont les stratégies couramment adoptées par les entreprises pour étendre leur empreinte mondiale et leurs portefeuilles de produits. De plus, les acteurs du marché des contrôles de qualité moléculaires se concentrent sur la stratégie de collaboration pour élargir leur clientèle, ce qui, à son tour, leur permet de conserver leur marque à l'échelle mondiale.
Marché des contrôles de qualité moléculaires - par produit
- Contrôles indépendants
- Contrôles spécifiques à l'instrument
Marché des contrôles de qualité moléculaires - par type d'analyte
- Contrôles à analyte unique
- Contrôles multi-analytes
Marché des contrôles de qualité moléculaires par application
- Maladies infectieuses
- Oncologie
- Tests génétiques
- Autres applications
Marché des contrôles de qualité moléculaires par utilisateur final
- Laboratoires cliniques
- Hôpitaux
- Fabricants de DIV et organismes de recherche sous contrat
- Instituts universitaires et de recherche
- Autres utilisateurs finaux
Marché des contrôles de qualité moléculaires par zone géographique
- Amérique du Nord
- États-Unis
- Canada
- Mexique
- Europe
- France
- Allemagne
- Italie
- Royaume-Uni
- Espagne
- Reste de l'Europe
- Asie-Pacifique (APAC)
- Chine
- Inde
- Sud Corée
- Japon
- Australie
- Reste de l'Asie-Pacifique
- Moyen-Orient et Afrique (MEA)
- Afrique du Sud
- Arabie saoudite
- EAU
- Reste du Moyen-Orient et Afrique
- Amérique du Sud et centrale (SCAM)
- Brésil
- Argentine
- Reste de l'Amérique du Sud et centrale
Profils des entreprises
- THERMO FISHER SCIENTIFIC, INC.
- BIO-RAD LABORATORIES, INC.
- F. HOFFMANN LA-ROCHE LTD.
- Abbott
- Quidel Corporation
- Qnostics
- Maine Molecular Controls, Inc.
- Zeptometrix Corporation
- Microbiologie
- Seracare Life Sciences
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Molecular quality controls help to monitor the performance of testing procedures. These tests are helpful to achieve critical and accurate diagnostic information. These controls are used to determine transmissible and genetic diseases too. Moreover, the molecular quality controls also help to monitor the performance of nucleic acid testing protocols for healthcare associated infections, viral load assays and sexually transmitted infections.
The global molecular quality controls market growth is mainly attributed to factors such growing funds for genomics, declining cost of sequencing procedures, and increasing prevalence of genetic diseases fuel the growth of the market. Moreover, rising adoption of molecular diagnostics is likely to create growth opportunities for the market
The molecular quality controls market majorly consists of the players such as Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, F. Hoffmann La-Roche Ltd, Abbott, Quidel Corporation, Qnostics, Maine Molecular Controls, Inc., Zeptometrix Corporation, Microbiologics, and Seracare Life Sciences among others.
The List of Companies - Molecular Quality Controls Market
- TOHERMO FISHER SCIENTIFIC, INC.
- BI-RAD LABORATORIES, INC.
- F. HOFFMANN LA-ROCHE LTD.
- Abbott
- Quidel Corporation
- Qnostics
- Maine Molecular Controls, Inc.
- Zeptometrix Corporation
- Microbiologics
- Seracare Life Sciences
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jun 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jun 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jun 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Jun 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Jun 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Jun 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)